Essential structural requirements and additive effects for flavonoids to scavenge methylglyoxal

Journal of Agricultural and Food Chemistry

Volumn 62, Issue 14, 2014, Pages 3202-3210

  Shao, Xi ^a   Chen, Huadong ^a   Zhu, Yingdong ^a   Sedighi, Rashin ^a   Ho, Chi Tang ^b   Sang, Shengmin ^a  

^a NORTH CAROLINA A AND T STATE UNIVERSITY   (United States)

^b RUTGERS UNIVERSITY   (United States)

Author keywords

additive effect; AGEs; flavonoids; MGO trapping; SAR

Indexed keywords

PHENOLS;

1 ,3 ,5-TRIHYDROXYBENZENE; ADDITIVE EFFECTS; ADVANCED GLYCATION END PRODUCTS; AGES; MGO; SAR; SCAVENGING ACTIVITIES; STRUCTURAL REQUIREMENTS;

FLAVONOIDS;

EID: 84897972566     PISSN: 00218561     EISSN: 15205118     Source Type: Journal    
DOI: 10.1021/jf500204s     Document Type: Article

References (36)

1. Kalapos, M. P. Where does plasma methylglyoxal originate from? Diabetes Res. Clin. Pract. 2013, 99, 260-271
2. Negre-Salvayre, A.; Salvayre, R.; Auge, N.; Pamplona, R.; Portero-Otin, M. Hyperglycemia and glycation in diabetic complications Antioxid. Redox Signaling 2009, 11, 3071-3109
3. Matafome, P.; Sena, C.; Seica, R. Methylglyoxal, obesity, and diabetes Endocrine 2013, 43, 472-484
4. Wang, H.; Meng, Q. H.; Gordon, J. R.; Khandwala, H.; Wu, L. Proinflammatory and proapoptotic effects of methylglyoxal on neutrophils from patients with type 2 diabetes mellitus Clin. Biochem. 2007, 40, 1232-1239
5. Perkins, B. A.; Rabbani, N.; Weston, A.; Ficociello, L. H.; Adaikalakoteswari, A.; Niewczas, M.; Warram, J.; Krolewski, A. S.; Thornalley, P. Serum levels of advanced glycation endproducts and other markers of protein damage in early diabetic nephropathy in type 1 diabetes PloS One 2012, 7 e35655
6. Singh, R.; Barden, A.; Mori, T.; Beilin, L. Advanced glycation end-products: A review Diabetologia 2001, 44, 129-146
7. Crisostomo, J.; Matafome, P.; Santos-Silva, D.; Rodrigues, L.; Sena, C. M.; Pereira, P.; Seica, R. Methylglyoxal chronic administration promotes diabetes-like cardiac ischaemia disease in Wistar normal rats Nutr. Metab. Cardiovasc. Dis. 2013, 23, 1223-1230
8. Lee, B. H.; Hsu, W. H.; Hsu, Y. W.; Pan, T. M. Dimerumic acid attenuates receptor for advanced glycation endproducts signal to inhibit inflammation and diabetes mediated by Nrf2 activation and promotes methylglyoxal metabolism into d -lactic acid Free Radicals Biol. Med. 2013, 60, 7-16
9. Dhar, A.; Dhar, I.; Jiang, B.; Desai, K. M.; Wu, L. Chronic methylglyoxal infusion by minipump causes pancreatic β-cell dysfunction and induces type 2 diabetes in Sprague-Dawley rats Diabetes 2011, 60, 899-908
10. Guo, Q.; Mori, T.; Jiang, Y.; Hu, C.; Osaki, Y.; Yoneki, Y.; Sun, Y.; Hosoya, T.; Kawamata, A.; Ogawa, S.; Nakayama, M.; Miyata, T.; Ito, S. Methylglyoxal contributes to the development of insulin resistance and salt sensitivity in Sprague-Dawley rats J. Hypertens. 2009, 27, 1664-1671
11. Giacco, F.; Du, X.; D'Agati, V. D.; Milne, R.; Sui, G.; Geoffrion, M.; Brownlee, M. Knockdown of glyoxalase 1 mimics diabetic nephropathy in nondiabetic mice Diabetes 2014, 63, 291-299
12. Wang, Y.; Ho, C. T. Flavour chemistry of methylglyoxal and glyoxal Chem. Soc. Rev. 2012, 41, 4140-4149
13. Peng, X.; Ma, J.; Chen, F.; Wang, M. Naturally occurring inhibitors against the formation of advanced glycation end-products Food Funct. 2011, 2, 289-301
14. Shapiro, H. K. Carbonyl-trapping therapeutic strategies Am. J. Ther. 1998, 5, 323-353
15. Thomas, M. C.; Baynes, J. W.; Thorpe, S. R.; Cooper, M. E. The role of AGEs and AGE inhibitors in diabetic cardiovascular disease Curr. Drug Targets 2005, 6, 453-474
16. Tanaka, N.; Yonekura, H.; Yamagishi, S.; Fujimori, H.; Yamamoto, Y.; Yamamoto, H. The receptor for advanced glycation end products is induced by the glycation products themselves and tumor necrosis factor-α through nuclear factor-κB, and by 17β-estradiol through Sp-1 in human vascular endothelial cells J. Biol. Chem. 2000, 275, 25781-25790
17. Webster, J.; Urban, C.; Berbaum, K.; Loske, C.; Alpar, A.; Gartner, U.; de Arriba, S. G.; Arendt, T.; Munch, G. The carbonyl scavengers aminoguanidine and tenilsetam protect against the neurotoxic effects of methylglyoxal Neurotoxic. Res. 2005, 7, 95-101
18. Price, D. L.; Rhett, P. M.; Thorpe, S. R.; Baynes, J. W. Chelating activity of advanced glycation end-product inhibitors J. Biol. Chem. 2001, 276, 48967-48972
19. Blatnik, M.; Frizzell, N.; Thorpe, S. R.; Baynes, J. W. Inactivation of glyceraldehyde-3-phosphate dehydrogenase by fumarate in diabetes: Formation of S -(2-succinyl)cysteine, a novel chemical modification of protein and possible biomarker of mitochondrial stress Diabetes 2008, 57, 41-49
20. Beisswenger, P.; Ruggiero-Lopez, D. Metformin inhibition of glycation processes Diabetes Metab. 2003, 29, 6S95-6S103
21. Beisswenger, P. J.; Howell, S. K.; Touchette, A. D.; Lal, S.; Szwergold, B. S. Metformin reduces systemic methylglyoxal levels in type 2 diabetes Diabetes 1999, 48, 198-202
22. Nagaraj, R. H.; Sarkar, P.; Mally, A.; Biemel, K. M.; Lederer, M. O.; Padayatti, P. S. Effect of pyridoxamine on chemical modification of proteins by carbonyls in diabetic rats: Characterization of a major product from the reaction of pyridoxamine and methylglyoxal Arch. Biochem. Biophys. 2002, 402, 110-119
23. Voziyan, P. A.; Metz, T. O.; Baynes, J. W.; Hudson, B. G. A post-Amadori inhibitor pyridoxamine also inhibits chemical modification of proteins by scavenging carbonyl intermediates of carbohydrate and lipid degradation J. Biol. Chem. 2002, 277, 3397-3403
24. Thornalley, P. J. Use of aminoguanidine (Pimagedine) to prevent the formation of advanced glycation endproducts Arch. Biochem. Biophys. 2003, 419, 31-40
25. Wu, C. H.; Yen, G. C. Inhibitory effect of naturally occurring flavonoids on the formation of advanced glycation endproducts J. Agric. Food Chem. 2005, 53, 3167-3173
26. 4 sugar fragments J. Agric. Food Chem. 2005, 53, 4130-4135
27. Shao, X.; Bai, N.; He, K.; Ho, C. T.; Yang, C. S.; Sang, S. Apple polyphenols, phloretin and phloridzin: New trapping agents of reactive dicarbonyl species Chem. Res. Toxicol. 2008, 21, 2042-2050
28. Sang, S.; Shao, X.; Bai, N.; Lo, C. Y.; Yang, C. S.; Ho, C. T. Tea polyphenol (-)-epigallocatechin-3-gallate: A new trapping agent of reactive dicarbonyl species Chem. Res. Toxicol. 2007, 20, 1862-1870
29. Lv, L.; Shao, X.; Chen, H.; Ho, C. T.; Sang, S. Genistein inhibits advanced glycation end product formation by trapping methylglyoxal Chem. Res. Toxicol. 2011, 24, 579-586
30. ε-(Carboxyethyl)lysine, a product of the chemical modification of proteins by methylglyoxal, increases with age in human lens proteins Biochem. J. 1997, 324 (Part 2) 565-570
31. Odani, H.; Shinzato, T.; Usami, J.; Matsumoto, Y.; Brinkmann Frye, E.; Baynes, J. W.; Maeda, K. Imidazolium crosslinks derived from reaction of lysine with glyoxal and methylglyoxal are increased in serum proteins of uremic patients: Evidence for increased oxidative stress in uremia FEBS Lett. 1998, 427, 381-385
32. Beecher, G. R. Overview of dietary flavonoids: Nomenclature, occurrence and intake J. Nutr. 2003, 133, 3248S-3254S
33. Takasawa, R.; Takahashi, S.; Saeki, K.; Sunaga, S.; Yoshimori, A.; Tanuma, S. Structure-activity relationship of human GLO I inhibitory natural flavonoids and their growth inhibitory effects Bioorg. Med. Chem. 2008, 16, 3969-3975
34. Maher, P.; Dargusch, R.; Ehren, J. L.; Okada, S.; Sharma, K.; Schubert, D. Fisetin lowers methylglyoxal dependent protein glycation and limits the complications of diabetes PloS One 2011, 6 e21226
35. Chun, O. K.; Chung, S. J.; Song, W. O. Estimated dietary flavonoid intake and major food sources of U.S. adults J. Nutr. 2007, 137, 1244-1252
36. Sampson, L.; Rimm, E.; Hollman, P. C.; de Vries, J. H.; Katan, M. B. Flavonol and flavone intakes in US health professionals J. Am. Diet. Assoc. 2002, 102, 1414-1420